106 related articles for article (PubMed ID: 7108275)
1. Elevation of levels of IgE antibody to tetanus toxin in individuals vaccinated with diphtheria-pertussis-tetanus vaccine.
Matuhasi T; Ikegami H
J Infect Dis; 1982 Aug; 146(2):290. PubMed ID: 7108275
[No Abstract] [Full Text] [Related]
2. Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis.
Aalberse RC; Grüber C; Ljungman M; Kakat S; Wahn U; Niggemann B; Nilsson LJ
Pediatr Allergy Immunol; 2019 Dec; 30(8):841-847. PubMed ID: 31419322
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine.
Grüber C; Lau S; Dannemann A; Sommerfeld C; Wahn U; Aalberse RC
J Immunol; 2001 Aug; 167(4):2411-7. PubMed ID: 11490032
[TBL] [Abstract][Full Text] [Related]
4. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
[TBL] [Abstract][Full Text] [Related]
5. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
6. [Production of IgE antibody against improved DPT vaccine in rats].
Machida Y; Fukazawa N; Kanazawa G
Kansenshogaku Zasshi; 1982 Jul; 56(7):552-9. PubMed ID: 6818293
[No Abstract] [Full Text] [Related]
7. Diphtheria in vaccinated persons.
Rabo E
Scand J Infect Dis; 1987; 19(3):383-4. PubMed ID: 3497437
[No Abstract] [Full Text] [Related]
8. Capture EIA for determination of IgE to diphtheria and tetanus toxins in comparison to RIA.
Wahren E; Bengtsson C; Björkstén B; Mark A; Granström M
Vaccine; 1998; 16(9-10):873-6. PubMed ID: 9682330
[TBL] [Abstract][Full Text] [Related]
9. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
10. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
Vodicková M; Svandová E
Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
[No Abstract] [Full Text] [Related]
11. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
Huu TN; Phuong NT; Toan NT; Thang HV
Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
[TBL] [Abstract][Full Text] [Related]
12. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria, tetanus, pertussis: antibody detection in New Zealand.
Lau RC
N Z Med J; 1987 Aug; 100(829):481-3. PubMed ID: 3502676
[TBL] [Abstract][Full Text] [Related]
14. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
15. Acellular pertussis vaccines.
Hinman AR; Onorato IM
Pediatr Infect Dis J; 1987 Apr; 6(4):341-3. PubMed ID: 3495774
[No Abstract] [Full Text] [Related]
16. [Characteristics of dynamics of antibody formation in children with chronic tonsillitis and adenoid hypertrophy immunized with the anti-pertussis-diphtheria-tetanus vaccine].
Giulling EV; Voloshchuk MI; Chernata LI; Belen'kaia LV
Zh Ushn Nos Gorl Bolezn; 1978; (6):50-3. PubMed ID: 735359
[No Abstract] [Full Text] [Related]
17. [20 years' use of the diphtheria-pertussis-tetanus vaccine].
Fillastre C; Guerin N; Ajjan N; Triau R
Pediatrie; 1988; 43(1):73-9. PubMed ID: 3387184
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes after DTP immunization.
Habig WH; Holohan TV; Phillips TM
J Pediatr; 1988 Jan; 112(1):162-3. PubMed ID: 3257263
[No Abstract] [Full Text] [Related]
19. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
20. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
Habbu MK; Poonawalla CS; Parvatikar MS; Jadhav SS
Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394
[No Abstract] [Full Text] [Related]
[Next] [New Search]
